Doug Dayhoff

Doug is the CFO at INCOG. He has 20 years of experience leading teams, managing operations and raising capital in high-growth companies. Most recently, he served as Executive Director of Cell Manufacturing Solutions with Cook Regentec, a corporate venture studio focused on regenerative medicine technologies.  He also served as board chair for Sexton Biotechnologies—a provider of bioprocessing tools for cell and gene therapies, which was acquired by Biolife Solutions (NASDAQ: BLFS) in 2021.

Prior to that, Doug served in various executive roles with organizations whose successes were based on building teams of amazing people and developing company cultures that balanced competitiveness with collegiality, and passion with analysis and planning.

Doug holds a BA in philosophy from Indiana University and an MBA from the Tuck School of Business at Dartmouth College. He and his wife have two college-age sons, and they all like to spend their free time in mountain towns and wild places.